MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qai.0b013e318198a7e6

Медицинская библиотека · Journal of acquired immune deficiency syndromes (1999) · 2009

A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis.

Chen Marcus Y, Millwood Iona Y, Wand Handan, Poynten Mary, Law Matthew, Kaldor John M, Wesselingh Steve, Price Clare F, Clark Laura J, Paull Jeremy R A, Fairley Christopher K

Клиническое исследование I фазыСтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

To determine the safety of the candidate vaginal microbicide SPL7013 gel (VivaGel) when applied to the penis.

METHODS

A randomized, double-blind, placebo-controlled study. Thirty-six healthy men (18 circumcised, 18 uncircumcised) were randomized in a 2:1 ratio and treated with 3% SPL7013 gel (n = 24) or placebo gel (n = 12), applied once daily for 7 days. Genital toxicity was determined by interview, diary, and examination.

RESULTS

There were 10 genital adverse events (AEs) in 6 men (25%) receiving SPL7013 gel and 5 genital AEs in 4 men (33%) receiving the placebo that were possibly or probably related to the study product (difference of -8%, 95% confidence interval: -40% to 23%, P = 0.70). The most common genital AEs were genital pruritus and application site erythema. All genital AEs were mild (grade 1), and all but 1 in the placebo group were transient. Analysis of vital signs, nongenital AEs, and laboratory results indicated no safety or tolerability issues with SPL7013 gel, irrespective of circumcision status. There was no detectable absorption of SPL7013 into the plasma.

CONCLUSIONS

Three percent SPL7013 gel was safe and well tolerated, and comparable with placebo, when administered to the penis of both circumcised and uncircumcised men once daily for 7 days, with no evidence of systemic absorption or toxicity.

Для цитирования: Chen Marcus Y, Millwood Iona Y, Wand Handan, Poynten Mary, Law Matthew, Kaldor John M, Wesselingh Steve, Price Clare F, Clark Laura J, Paull Jeremy R A, Fairley Christopher K. A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis.. Journal of acquired immune deficiency syndromes (1999). 2009. DOI: 10.1097/qai.0b013e318198a7e6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.